Florida 2023 Regular Session

Florida House Bill H0203 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11
22
33 HB 203 2023
44
55
66
77 CODING: Words stricken are deletions; words underlined are additions.
88 hb0203-00
99 Page 1 of 12
1010 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1111
1212
1313
1414 A bill to be entitled 1
1515 An act relating to access to pharmacies and 2
1616 prescription drugs under insurance and pharmacy 3
1717 benefit managers policies; amending s. 624.3161, F.S.; 4
1818 requiring the Office of Insurance Regulation to 5
1919 examine pharmacy benefit managers to ascertain 6
2020 compliance with specified laws; conforming a provision 7
2121 to changes made by the act; amending s. 624.490, F.S.; 8
2222 requiring the office to suspend or revoke 9
2323 registrations for pharmacy benefit managers and impose 10
2424 fines and civil penalties for certain violations; 11
2525 providing fines and civil penalties; providing that 12
2626 such violations are unfair methods of competition or 13
2727 unfair or deceptive acts or practices; providing that 14
2828 such violations are subject to certain actions, 15
2929 remedies, and penalties; providing applicability; 16
3030 creating s. 624.4901, F.S.; providing purpose; 17
3131 providing definitions; requiring pharmacy benefit 18
3232 managers to establish pharmacy benefit networks for a 19
3333 specified purpose; requiring pharmacy benefit managers 20
3434 to have standard contracts with pharmacies; providing 21
3535 requirements for such contracts' terms and conditions; 22
3636 requiring pharmacy benefit managers to provide copies 23
3737 of such standard contracts within a specified 24
3838 timeframe to requesting pharmacies and pharmacists; 25
3939
4040 HB 203 2023
4141
4242
4343
4444 CODING: Words stricken are deletions; words underlined are additions.
4545 hb0203-00
4646 Page 2 of 12
4747 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
4848
4949
5050
5151 prohibiting pharmacy benefit managers from denying 26
5252 pharmacies and pharmacists in the state the right to 27
5353 participate as contract providers under certain 28
5454 circumstances; providing construction; authorizing 29
5555 certain persons and entities to bring actions and 30
5656 injunctive relief under certain circumstances; 31
5757 authorizing the Department of Financial Services to 32
5858 adopt rules; creating s. 624.4902, F.S.; providing 33
5959 purpose; providing definitions; prohibiting pharmacy 34
6060 benefit managers from engaging in certain acts against 35
6161 patients and covered individuals; providing that such 36
6262 acts are unfair methods of competition or unfair or 37
6363 deceptive acts or practices; providing that such acts 38
6464 are subject to certain actions, remedies, and 39
6565 penalties; authorizing the department to adopt rules; 40
6666 creating s. 627.42398, F.S.; providing definitions; 41
6767 prohibiting health insurers and pharmacy benefit 42
6868 managers from engaging in certain acts relating to 43
6969 covered clinician-administered drugs; providing that 44
7070 such acts constitute unfair methods of competition or 45
7171 unfair or deceptive acts or practices and are subje ct 46
7272 to certain actions, remedies, and penalties; providing 47
7373 an effective date. 48
7474 49
7575 Be It Enacted by the Legislature of the State of Florida: 50
7676
7777 HB 203 2023
7878
7979
8080
8181 CODING: Words stricken are deletions; words underlined are additions.
8282 hb0203-00
8383 Page 3 of 12
8484 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
8585
8686
8787
8888 51
8989 Section 1. Subsections (1) and (3) of section 624.3161, 52
9090 Florida Statutes, are amended to read: 53
9191 624.3161 Market conduct examinations. — 54
9292 (1) As often as it deems necessary, the office shall 55
9393 examine each pharmacy benefit manager as defined in s. 624.490, 56
9494 each licensed rating organization, each advisory organization, 57
9595 each group, association, carrier, as defined in s . 440.02, or 58
9696 other organization of insurers which engages in joint 59
9797 underwriting or joint reinsurance, and each authorized insurer 60
9898 transacting in this state any class of insurance to which the 61
9999 provisions of chapter 627 are applicable. The examination shall 62
100100 be for the purpose of ascertaining compliance by the person 63
101101 examined with the applicable provisions of chapters 440, 624, 64
102102 626, 627, and 635. 65
103103 (3) The examination may be conducted by an independent 66
104104 professional examiner under contract to the office, in whi ch 67
105105 case payment shall be made directly to the contracted examiner 68
106106 by the entity insurer examined in accordance with the rates and 69
107107 terms agreed to by the office and the examiner. 70
108108 Section 2. Subsections (6) and (7) of section 624.490, 71
109109 Florida Statutes, are renumbered as subsections (8) and (9), 72
110110 respectively, and new subsections (6) and (7) are added to that 73
111111 section, to read: 74
112112 624.490 Registration of pharmacy benefit managers. — 75
113113
114114 HB 203 2023
115115
116116
117117
118118 CODING: Words stricken are deletions; words underlined are additions.
119119 hb0203-00
120120 Page 4 of 12
121121 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
122122
123123
124124
125125 (6)(a) The office may suspend or revoke a pharmacy benefit 76
126126 manager's registration or impose a fine or civil penalty if it 77
127127 finds that the pharmacy benefit manager has violated s. 78
128128 624.4901, s. 624.4902, s. 624.491, s. 627.42398, s. 627.6131, s. 79
129129 627.64741, s. 627.6572, s. 641.314, or s. 641.3155. The fine or 80
130130 civil penalty shall be in the amount of $10,000 for each 81
131131 violation, which shall accrue for each day the pharmacy benefit 82
132132 manager is in violation of the law. 83
133133 (b) The violation of any section enumerated in paragraph 84
134134 (a) constitutes an unfair method of competition or an unfair or 85
135135 deceptive act or practice, subject to actions, remedies, and 86
136136 penalties provided by the Florida Deceptive and Unfair Trade 87
137137 Practices Act and consumer protection laws. 88
138138 (7) Subsection (6) applies to contracts between a pharmacy 89
139139 benefit manager and a pharmacy that participates in a retail 90
140140 pharmacy network of the pharmacy benefit manager. 91
141141 Section 3. Section 624.4901, Florida Statutes, is created 92
142142 to read: 93
143143 624.4901 Pharmacy benefit manager contracts with 94
144144 pharmacies.— 95
145145 (1) The purpose of this section is to give patients 96
146146 convenient access to affordable prescription drugs through a 97
147147 pharmacy of their choice. 98
148148 (2) As used in this section, the term: 99
149149 (a) "Affiliate" means a pharmacy in which a pharmacy 100
150150
151151 HB 203 2023
152152
153153
154154
155155 CODING: Words stricken are deletions; words underlined are additions.
156156 hb0203-00
157157 Page 5 of 12
158158 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
159159
160160
161161
162162 benefit manager, directly or indirectly, has an investment or 101
163163 ownership interest or shares common ownership. 102
164164 (b) "Pharmacy" means a pharmacy licensed under chapter 103
165165 465, a nonresident pharmacy registered under s. 465.0156, or a 104
166166 nonresident pharmacy or outsourcing facility holding an active 105
167167 permit pursuant to s. 4 65.0158 to dispense drugs to patients 106
168168 located in this state. 107
169169 (c) "Pharmacy benefit manager" has the same meaning as in 108
170170 s. 624.490(1). 109
171171 (3) A pharmacy benefit manager shall establish a 110
172172 reasonably adequate and accessible pharmacy benefit network to 111
173173 provide patients with convenient access to prescription drugs 112
174174 through pharmacies that are located within a reasonable distance 113
175175 from a patient's residence. 114
176176 (4) A pharmacy benefit manager shall have a standard 115
177177 contract with reasonable and relevant terms and cond itions of 116
178178 participation in the pharmacy benefit network, whereby any 117
179179 willing pharmacy may participate as a network pharmacy. Terms 118
180180 and conditions must include provisions reasonable and relevant 119
181181 to unique pharmacy, pharmacy business, and pharmacy service 120
182182 models. 121
183183 (5) A pharmacy benefit manager shall provide a copy of the 122
184184 standard contract to a requesting pharmacy or pharmacist within 123
185185 7 business days after receiving such a request from the pharmacy 124
186186 or pharmacist. 125
187187
188188 HB 203 2023
189189
190190
191191
192192 CODING: Words stricken are deletions; words underlined are additions.
193193 hb0203-00
194194 Page 6 of 12
195195 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
196196
197197
198198
199199 (6) If a pharmacy benefit manager's affilia te participates 126
200200 in the pharmacy benefit network, the pharmacy benefit manager 127
201201 may not deny another pharmacy or pharmacist in this state the 128
202202 right to participate as a contract provider under the policy or 129
203203 plan, provided that the pharmacy or pharmacist agree s to: 130
204204 (a) Provide pharmaceutical services that meet all 131
205205 reasonable and relevant terms and conditions. 132
206206 (b) Include the same administrative, financial, and 133
207207 professional conditions that apply to pharmacy and pharmacists 134
208208 that have been designated as provid ers under the policy or plan. 135
209209 (7) The decision of a pharmacy or pharmacist to accept a 136
210210 contract with the pharmacy benefit manager is not admissible 137
211211 proof that the contract is reasonable and relevant. 138
212212 (8) Without regard to any other remedy or relief to which 139
213213 a pharmacy is entitled, a pharmacy, a pharmacist, or a person, 140
214214 firm, corporation, association, entity, or any agent or employee 141
215215 of a pharmacy or pharmacist which is aggrieved by a violation of 142
216216 this section may bring an action to recover damages, plus 143
217217 attorney fees and costs, and injunctive relief. 144
218218 (9) The department may adopt rules to implement this 145
219219 section. 146
220220 Section 4. Section 624.4902, Florida Statutes, is created 147
221221 to read: 148
222222 624.4902 Pharmacy benefit managers' prohibited acts. — 149
223223 (1) The purpose of this section is to protect patient 150
224224
225225 HB 203 2023
226226
227227
228228
229229 CODING: Words stricken are deletions; words underlined are additions.
230230 hb0203-00
231231 Page 7 of 12
232232 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
233233
234234
235235
236236 welfare by establishing minimum standards for patient access to 151
237237 a pharmacy provider and by prohibiting restrictions imposed by a 152
238238 pharmacy benefit manager on a patient's right to choose a 153
239239 pharmacy. 154
240240 (2) As used in this section, the term: 155
241241 (a) "Affiliate" means a pharmacy in which a pharmacy 156
242242 benefit manager, directly or indirectly, has an investment or 157
243243 ownership interest or shares common ownership. As used in this 158
244244 paragraph, the term "pharmacy" has the same meaning as in s. 159
245245 624.4901(2). 160
246246 (b) "Pharmacy benefit manager" has the same meaning as in 161
247247 s. 624.490(1). 162
248248 (c) "Wholesale acquisition cost" means the amount that a 163
249249 pharmaceutical wholesaler charges for a pharmaceutical product 164
250250 as listed on the pharmacy's billing inv oice. 165
251251 (3) A pharmacy benefit manager may not: 166
252252 (a) Offer, incentivize, or implement a plan design that 167
253253 requires a patient or covered individual to use an affiliate; 168
254254 (b) Refer or incentivize a patient or covered individual 169
255255 to use an affiliate or any ph armacy in which the pharmacy 170
256256 benefit manager has any direct or indirect financial interest or 171
257257 ownership; 172
258258 (c) Restrict the choice of a patient or covered individual 173
259259 of an in-network provider for prescription drugs; 174
260260 (d) Reimburse a pharmacy or pharmacist in this state an 175
261261
262262 HB 203 2023
263263
264264
265265
266266 CODING: Words stricken are deletions; words underlined are additions.
267267 hb0203-00
268268 Page 8 of 12
269269 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
270270
271271
272272
273273 amount less than the amount that the pharmacy benefit manager 176
274274 reimburses an affiliate for providing the same drug products, 177
275275 drug product ingredients, or pharmacist services; or 178
276276 (e) Reimburse a pharmacy or pharmacist in this state for a 179
277277 drug product, drug product ingredient, or pharmacist services an 180
278278 amount less than the national average drug acquisition cost, or, 181
279279 if the national average drug acquisition cost is unavailable, 182
280280 the wholesale acquisition cost. 183
281281 (4) The commission of any act prohibited under subsection 184
282282 (3) constitutes an unfair method of competition or an unfair or 185
283283 deceptive act or practice, subject to actions, remedies, and 186
284284 penalties provided by the Florida Deceptive and Unfair Trade 187
285285 Practices Act and consumer protection laws . 188
286286 (5) The department may adopt rules necessary to implement 189
287287 this section. 190
288288 Section 5. Section 627.42398, Florida Statutes, is created 191
289289 to read: 192
290290 627.42398 Coverage of clinician -administered drugs by 193
291291 health insurers and pharmacy benefit managers. — 194
292292 (1) As used in this section, the term: 195
293293 (a) "Clinician-administered drug" means a prescription 196
294294 drug other than a vaccine which: 197
295295 1. Has not been approved by the United States Food and 198
296296 Drug Administration as a self -administered drug or self -199
297297 administered biologic, or cannot reasonably be administered by 200
298298
299299 HB 203 2023
300300
301301
302302
303303 CODING: Words stricken are deletions; words underlined are additions.
304304 hb0203-00
305305 Page 9 of 12
306306 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
307307
308308
309309
310310 the patient to whom the drug is prescribed or by an individual 201
311311 other than a health care provider. 202
312312 2. Is typically administered in a physician's office, 203
313313 hospital, outpatient infusion center, or other clinical setting. 204
314314 (b) "Health care provider" means a health care 205
315315 professional, health care facility, or entity licensed or 206
316316 certified to provide health care services in this state which 207
317317 meets the criteria established by the Department of Health. 208
318318 (c) "Insurer" means an insurer as defined in s. 624.03 209
319319 which provides health insurance coverage, a multiple -employer 210
320320 welfare arrangement as def ined in s. 624.437(1), self -insurance 211
321321 as defined in s. 624.031, a prepaid limited health service 212
322322 organization as defined in s. 636.003(7), a health maintenance 213
323323 organization as defined in s. 641.19(12), a prepaid health 214
324324 clinic as defined in s. 641.402, a fr aternal benefit society as 215
325325 defined in s. 632.601 which provides health care benefits, or 216
326326 any health care arrangement that assumes some risk. 217
327327 (d) "Participating provider" means a health care provider 218
328328 that participates in the network of an insurer or pharm acy 219
329329 benefit manager. 220
330330 (e) "Pharmacy benefit manager" has the same meaning as in 221
331331 s. 624.490(1). 222
332332 (f) "White bagging" means the policy of an insurer or 223
333333 pharmacy benefit manager which requires a prescription drug to 224
334334 be: 225
335335
336336 HB 203 2023
337337
338338
339339
340340 CODING: Words stricken are deletions; words underlined are additions.
341341 hb0203-00
342342 Page 10 of 12
343343 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
344344
345345
346346
347347 1. Dispensed by a specialty pharmac y selected by the 226
348348 insurer or pharmacy benefit manager. 227
349349 2. Transported to a health care provider for 228
350350 administration to a patient. 229
351351 230
352352 As used in this paragraph, the term "specialty pharmacy" means a 231
353353 pharmacy that focuses on high -cost medications and personal ized 232
354354 support for patients with chronic or complex conditions. 233
355355 (2) An insurer or pharmacy benefit manager that covers a 234
356356 clinician-administered drug may not: 235
357357 (a) Condition, deny, or reduce payment to a participating 236
358358 provider for providing the covered cli nician-administered drug 237
359359 and related services to an insured if all the criteria for the 238
360360 medical necessity for providing and administering the clinician -239
361361 administered drug are met, regardless of whether the clinician -240
362362 administered drug is obtained from a phar macy selected by the 241
363363 insurer or pharmacy benefit manager. For the purposes of this 242
364364 section, the location of receiving the clinician -administered 243
365365 drug may not be considered a medical necessity criterion. 244
366366 (b) Interfere with the insured's right to choose to obtain 245
367367 the covered clinician -administered drug from a participating 246
368368 provider or a pharmacy of choice, through any inducement, 247
369369 steering, or financial or other incentive offer. 248
370370 (c) Require the covered clinician -administered drug to be 249
371371 dispensed by a pharm acy selected by the insurer or pharmacy 250
372372
373373 HB 203 2023
374374
375375
376376
377377 CODING: Words stricken are deletions; words underlined are additions.
378378 hb0203-00
379379 Page 11 of 12
380380 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
381381
382382
383383
384384 benefit manager, including, but not limited to, through white 251
385385 bagging. 252
386386 (d) If the covered clinician -administered drug is not 253
387387 dispensed by a pharmacy selected by the insurer or pharmacy 254
388388 benefit manager: 255
389389 1. Reimburse for the clinician -administered drug at a 256
390390 lesser amount than the amount that would otherwise be 257
391391 reimbursed; 258
392392 2. Limit or exclude coverage or benefits for the 259
393393 clinician-administered drug; or 260
394394 3. Require the insured to pay an additional fee, a higher 261
395395 copayment, a higher coinsurance, a second copayment, a second 262
396396 coinsurance, or any other form of an increased cost -sharing 263
397397 amount over the price paid for the clinician -administered drug 264
398398 dispensed by a pharmacy selected by the insurer or pharmacy 265
399399 benefit manager. 266
400400 (e) Require that the covered clinician -administered drug 267
401401 be administered using home infusion or be sent directly to a 268
402402 third party or to the insured for home infusion, unless the 269
403403 insured's treating physician determines that home infusion of 270
404404 the clinician-administered drug will not jeopardize the 271
405405 insured's health. 272
406406 (3) The commission of any act prohibited under subsection 273
407407 (2) constitutes an unfair method of competition or an unfair or 274
408408 deceptive act or practice, subject to actions, remedies, and 275
409409
410410 HB 203 2023
411411
412412
413413
414414 CODING: Words stricken are deletions; words underlined are additions.
415415 hb0203-00
416416 Page 12 of 12
417417 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
418418
419419
420420
421421 penalties provided by the Florida Deceptive and Unfair Trade 276
422422 Practices Act and consumer protection laws. 277
423423 Section 6. This act shall take effect July 1, 2023. 278